Clinical and Economic Outcomes in Medicare Beneficiaries with Stage 3 or Stage 4 Chronic Kidney Disease and Anemia: The Role of Intravenous Iron Therapy

por Knight, Tyler, Ryan, Kellie, Schaefer, Caroline, D'Sylva, Lynell, Durden, Emily
Publicado 2010

An assessment of the future impact of alternative technologies on antibiotics markets

por Nwokoro, Ejike, Leach, Ross, Årdal, Christine, Baraldi, Enrico, Ryan, Kellie, Plahte, Jens
Publicado 2016

Real-World Costs of Adverse Events in First-Line Treatment of Metastatic Non-Small Cell Lung Cancer

por Engel-Nitz, Nicole M., Johnson, Michael P., Bunner, Scott H., Ryan, Kellie J.
Publicado 2020

The Comparative Economic Burden of Mild, Moderate, and Severe Fibromyalgia: Results from a Retrospective Chart Review and Cross-Sectional Survey of Working-Age U.S. Adults

por Chandran, Arthi, Schaefer, Caroline, Ryan, Kellie, Baik, Rebecca, McNett, Michael, Zlateva, Gergana
Publicado 2012

Association of RSV-related hospitalization and non-compliance with Palivizumab among commercially insured infants: a retrospective claims analysis

por Stewart, Dan L, Ryan, Kellie J, Seare, Jerry G, Pinsky, Brett, Becker, Laura, Frogel, Michael
Publicado 2013

The impact of initial antibiotic treatment failure: real-world insights in patients with complicated, health care-associated intra-abdominal infection

por Peeters, Pascale, Ryan, Kellie, Karve, Sudeep, Potter, Danielle, Baelen, Elisa, Rojas-Farreras, Sonia, Rodríguez-Baño, Jesús
Publicado 2019

Long-term survival trends in patients with unresectable stage III non-small cell lung cancer receiving chemotherapy and radiation therapy: a SEER cancer registry analysis

por Hansen, Ryan N., Zhang, Yiduo, Seal, Brian, Ryan, Kellie, Yong, Candice, Darilay, Annie, Ramsey, Scott D.
Publicado 2020

Predictors of chemoradiotherapy versus single modality therapy and overall survival among patients with unresectable, stage III non-small cell lung cancer

por Bobbili, Priyanka, Ryan, Kellie, DerSarkissian, Maral, Dua, Akanksha, Yee, Christopher, Duh, Mei Sheng, Gomez, Jorge E.
Publicado 2020

Oncologist and Patient Preferences for Novel Agents in First-Line Treatment for Chronic Lymphocytic Leukemia: Commonalities and Disconnects

por Le, Hannah, Ryan, Kellie, Wahlstrom, Svea K, Maculaitis, Martine C, Will, Oliver, Mulvihill, Emily, LeBlanc, Thomas W
Publicado 2021

Health disparity in use of novel agents for first-line therapy in Black and White patients with chronic lymphocytic leukemia in the Department of Veterans Affairs

por Lucero, Kana Tai, Obodozie-Ofoegbu, Obiageri O, Nooruddin, Zohra, Ryan, Kellie, Castillo, Alyssa, Moore, Amanda M, Jones, Xavier, Frei, Christopher R
Publicado 2023

Real-world comparative effectiveness of acalabrutinib and ibrutinib in patients with chronic lymphocytic leukemia

por Roeker, Lindsey E., DerSarkissian, Maral, Ryan, Kellie, Chen, Yan, Duh, Mei Sheng, Wahlstrom, Svea K., Hakre, Shweta, Yu, Louise, Guo, Helen, Mato, Anthony R.
Publicado 2023

Results from a Real-World Multicenter Analysis of 482 Patients with Chronic Lymphocytic Leukemia Treated with Ibrutinib: A Look at Racial Differences

por Barrientos, Jacqueline C., Ayed, Ayed O., Cha, Agnes, Du, Senxi, Fang, Bruno, Hall, Ryan, Marks, Stanley M., Peng, Eileen, Rhodes, Joanna M., Ryan, Kellie, Winters, Sharon B., Yeung, Percy L., Hou, Jing-Zhou
Publicado 2023